From Multiomics to Mechanisms – Microbiome-Gut-Host Interactions as a Pathogenetic Driver of Parkinson's Disease Subtypes

Description of the granted funding

Parkinson's disease (PD) affects over 5 million people worldwide and 15.000 in Finland. The microbiota-gut-brain axis (MGBA) affects PD symptoms and pathology. Different subtypes of PD may exist with the location of first pathological changes being either in the brain (brain first) or the autonomic nervous system, specifically the gut (body first). Treatments that do not account for such differences will likely fail. We will identify subtypes of PD already in the prodromal phase (before motor symptoms appear) by analyzing genes, gut bacteria, metabolism, and inflammation to profile the MGBA in a large longitudinal cohort of elderly individuals and PD patients. We will compare MGBA pathway alterations (=biomarkers) across different subtypes and disease stages. We will confirm MGBA effects by assessing how fecal microbiota transplantation to rodent models worsens or alleviates PD pathology. This will eventually lead to new personalized treatments for PD.
Show more

Starting year

2021

End year

2025

Granted funding

Filip Scheperjans Orcid -palvelun logo
500 000 €

Funder

Research Council of Finland

Funding instrument

Academy projects

Other information

Funding decision number

342758

Fields of science

Biomedicine

Research fields

Systeemibiologia, bioinformatiikka

Themes

Nuori tutkijasukupolvi 2020

Identified topics

brain, neuroscience